Clinical Trial Update: Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

An ongoing phase 1/2 trial evaluating hypofractionated radiotherapy combined with immunochemotherapy as conversion therapy for gastroesophageal junction adenoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: West China Hospital | Conditions: Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy | Phase 1, Phase 2 | Status: RECRUITING